Wolverine Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,141
| Closed | -$996K | – | 1663 |
|
|
2025
Q3 | $886K | Sell |
3,141
-3,110
| -50% | -$902K | 0.01% | 762 |
|
|
2025
Q2 | $1.75M | Buy |
6,251
+2,505
| +67% | +$710K | 0.02% | 564 |
|
|
2025
Q1 | $1.17M | Sell |
3,746
-7,058
| -65% | -$2.08M | 0.01% | 639 |
|
|
2024
Q4 | $2.82M | Buy |
10,804
+5,473
| +103% | +$1.62M | 0.03% | 440 |
|
|
2024
Q3 | $1.72M | Sell |
5,331
-7,966
| -60% | -$2.61M | 0.02% | 544 |
|
|
2024
Q2 | $4.15M | Sell |
13,297
-1,216
| -8% | -$357K | 0.05% | 324 |
|
|
2024
Q1 | $4.13M | Buy |
+14,513
| New | +$4.25M | 0.05% | 323 |
|
|
2023
Q3 | – | Sell |
-38,204
| Closed | -$9.53M | – | 1872 |
|
|
2023
Q2 | $8.48M | Buy |
38,204
+21,826
| +133% | +$5.06M | 0.1% | 204 |
|
|
2023
Q1 | $3.96M | Buy |
+16,378
| New | +$4.02M | 0.05% | 372 |
|
|
2021
Q2 | – | Sell |
-135
| Closed | -$33K | – | 2147 |
|
|
2021
Q1 | $33K | Buy |
135
+127
| +1,588% | +$30.3K | ﹤0.01% | 1703 |
|
|
2020
Q4 | $1K | Buy |
+8
| New | +$1.84K | ﹤0.01% | 1592 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | -$2K | – | 1554 |
|
|
2020
Q2 | $2K | Buy |
+10
| New | +$2.28K | ﹤0.01% | 1469 |
|
|
2020
Q1 | – | Sell |
-412
| Closed | -$99K | – | 1426 |
|
|
2019
Q4 | $99K | Buy |
+412
| New | +$90.8K | ﹤0.01% | 1088 |
|
|
2018
Q3 | – | Sell |
-103
| Closed | -$19K | – | 1484 |
|
|
2018
Q2 | $19K | Sell |
103
-10,300
| -99% | -$1.82M | ﹤0.01% | 1309 |
|
|
2018
Q1 | $1.77M | Sell |
10,403
-328,420
| -97% | -$60.3M | 0.02% | 578 |
|
|
2017
Q4 | $58.9M | Buy |
338,823
+333,410
| +6,159% | +$59M | 0.6% | 30 |
|
|
2017
Q3 | $1.01M | Buy |
5,413
+5,173
| +2,155% | +$917K | 0.01% | 652 |
|
|
2017
Q2 | $41K | Buy |
240
+100
| +71% | +$16.3K | ﹤0.01% | 1136 |
|
|
2017
Q1 | $22K | Sell |
140
-302,413
| -100% | -$50.2M | ﹤0.01% | 1089 |
|
|
2016
Q4 | $44.2M | Buy |
+302,553
| New | +$45.5M | 0.57% | 36 |
|
|
2014
Q4 | – | Sell |
-14,891
| Closed | -$2.09M | – | 2134 |
|
|
2014
Q3 | $2.09M | Buy |
+14,891
| New | +$1.94M | 0.04% | 296 |
|
|
2014
Q1 | – | Sell |
-18,000
| Closed | -$2.05M | – | 2371 |
|
|
2013
Q4 | $2.05M | Buy |
18,000
+8,500
| +89% | +$967K | 0.04% | 327 |
|
|
2013
Q3 | $1.06M | Buy |
9,500
+3,000
| +46% | +$325K | 0.02% | 521 |
|
|
2013
Q2 | $641K | Buy |
+6,500
| New | +$675K | 0.02% | 633 |
|
Other funds holding AMGN
Wolverine Asset Management's AMGN Position: Q4 2025 in Review
Wolverine Asset Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 3,141 shares — an estimated $996K sold.
Wolverine Asset Management first reported a position in AMGN in Q2 2013 and held it in 24 quarters. The position peaked at $58.9M in Q4 2017. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Wolverine Asset Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Wolverine Asset Management sold 3,141 Amgen shares in Q4 2025, an estimated $996K.
- Wolverine Asset Management first reported a position in Amgen in Q2 2013 and held it in 24 quarters.
- Wolverine Asset Management's Amgen position peaked at $58.9M in Q4 2017.
- 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.